These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12593716)

  • 21. [Autoimmunization symptoms in thyroid diseases].
    Wegier A; Głab S; Wróblewska I; Nowak M; Feluś E
    Pol Tyg Lek; 1978 Dec; 33(52):2011-3. PubMed ID: 366580
    [No Abstract]   [Full Text] [Related]  

  • 22. Thyroid stimulating monoclonal antibodies: overcoming the road blocks and the way forward.
    McLachlan SM; Rapoport B
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):10-8. PubMed ID: 15212639
    [No Abstract]   [Full Text] [Related]  

  • 23. Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay.
    Vitti P; Rotella CM; Valente WA; Cohen J; Aloj SM; Laccetti P; Ambesi-Impiombato FS; Grollman EF; Pinchera A; Toccafondi R; Kohn LD
    J Clin Endocrinol Metab; 1983 Oct; 57(4):782-91. PubMed ID: 6136523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delineation of the discontinuous-conformational epitope of a monoclonal antibody displaying full in vitro and in vivo thyrotropin activity.
    Costagliola S; Bonomi M; Morgenthaler NG; Van Durme J; Panneels V; Refetoff S; Vassart G
    Mol Endocrinol; 2004 Dec; 18(12):3020-34. PubMed ID: 15319453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid antigen stimulates lymphocytes from patients with Graves' disease to produce thyroid-stimulating immunoglobulin (TSI).
    Knox AJ; von Westarp C; Row VV; Volpé R
    J Clin Endocrinol Metab; 1976 Aug; 43(2):330-7. PubMed ID: 181397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A study using FRTL-5 cell for detecting thyroid stimulating antibody activity in serum in patients with Graves disease].
    Li J; Gao H; Jin SX
    Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):392-4, 454. PubMed ID: 1684315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The relationship between antithyroglobulin antibodies and the evolution of thyroids diseases].
    Guntsche E; Rivero I; Staneloni L
    Medicina (B Aires); 1982; 42(4):369-74. PubMed ID: 15171016
    [No Abstract]   [Full Text] [Related]  

  • 28. [Thyroid-stimulating immunoglobulins and the incidence of postoperative hypothyroidism in patients with diffuse toxic goiter].
    Oleĭnik VA; Khalangot ND
    Vrach Delo; 1990 Nov; (11):95-8. PubMed ID: 1983051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship of thyroid antibodies to the postpartum recurrence of hyperthyroidism in Graves' disease.
    Chang TC; Chen FW; Tsai WY; Chen SH; Chang CC; Yu TK; Chen YP; Liaw KY
    Taiwan Yi Xue Hui Za Zhi; 1987 Feb; 86(2):171-7. PubMed ID: 2883249
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimental production of a thyroid-stimulating antithyroid antibody.
    McKenzie JM
    J Clin Endocrinol Metab; 1968 May; 28(5):596-602. PubMed ID: 4172455
    [No Abstract]   [Full Text] [Related]  

  • 31. [Membrane and thyroglobulin antibodies in Graves-Basedow disease treated with I-131 or thyrostatics].
    Czech W; Krzaścik E; Gardas A; Jastrzebska H; Bednarski A
    Pol Tyg Lek; 1986 Feb; 41(5):142-4. PubMed ID: 2423993
    [No Abstract]   [Full Text] [Related]  

  • 32. Adsorption of thyroid-stimulating antibody (TSAb) of Graves' disease by homologous and heterologous thyroid tissue.
    Zakarija M; McKenzie JM
    J Clin Endocrinol Metab; 1978 Oct; 47(4):906-8. PubMed ID: 95627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunological aspects of Basedow's disease].
    Winand R; Etienne-Decerf J; Cornet G; Mahieu P
    Bull Soc Belge Ophtalmol; 1988; 226():9-19. PubMed ID: 2908323
    [No Abstract]   [Full Text] [Related]  

  • 34. Small intestinal functions in Graves' disease with special reference to thyroid antibodies.
    Rao PS; Gupta PS; Rao B; Ghosh BK; Prakash P; Misra RC
    Indian J Med Res; 1981 Jan; 73():96-100. PubMed ID: 6894585
    [No Abstract]   [Full Text] [Related]  

  • 35. Hyperthyroid Graves' disease without detectable thyrotropin receptor antibodies.
    Ilicki A; Gamstedt A; Karlsson FA
    J Clin Endocrinol Metab; 1992 May; 74(5):1090-4. PubMed ID: 1349025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human monoclonal autoantibodies that react with both pancreatic islets and thyroid.
    Garzelli C; Taub FE; Jenkins MC; Drell DW; Ginsberg-Fellner F; Notkins AL
    J Clin Invest; 1986 May; 77(5):1627-31. PubMed ID: 3009548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive value of thyroid autoantibodies in the follow up of drug treated Graves' hyperthyroidism.
    Hampel R; Meng W; Meng S; Krabbe S; Ventz M; Männchen E; Kirsch G
    Radiobiol Radiother (Berl); 1987; 28(5):612-4. PubMed ID: 3441609
    [No Abstract]   [Full Text] [Related]  

  • 38. Evidence of intrathyroidal B-lymphocyte depletion after rituximab therapy in a patient with Graves' disease.
    El Fassi D; Clemmensen O; Nielsen CH; Silkiss RZ; Hegedüs L
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3762-3. PubMed ID: 17933978
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pathogenesis of diffuse toxic goiter].
    Neĭmark II; Kalinin AP
    Sov Med; 1991; (8):37-40. PubMed ID: 1763358
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of monoclonal antibodies directed towards the microsomal/microvillar thyroid autoantigen recognized by Hashimoto autoantibodies.
    Banga JP; Mirakian R; Hammond L; Pryce G; Bidey S; Bottazzo F; Weetman AP; McGregor AM; Roitt IM
    Clin Exp Immunol; 1986 Jun; 64(3):544-54. PubMed ID: 3791690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.